Adalimumab for psoriasis: Practical experience in a U.K. tertiary referral centre

British Journal of Dermatology

Volumn 163, Issue 4, 2010, Pages 859-862

  Warren, R B ^a   Brown, B C ^a   Lavery, D ^a   Griffiths, C E M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

adalimumab; biological therapy; psoriasis

Indexed keywords

ADALIMUMAB; CYCLOSPORIN A; EFALIZUMAB; ETANERCEPT; ETRETIN; FUMARIC ACID DERIVATIVE; INFLIXIMAB; METHOTREXATE; USTEKINUMAB;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALOPECIA; ARTHRALGIA; ARTICLE; ASTHMA; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPNEA; ECZEMA; EXTERNAL OTITIS; FATIGUE; FEMALE; FLU LIKE SYNDROME; GASTROINTESTINAL SYMPTOM; HUMAN; LOWER RESPIRATORY TRACT INFECTION; LYMPHOCYTOSIS; MALE; MOOD DISORDER; MOUTH ULCER; MYALGIA; PRIORITY JOURNAL; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; QUALITY OF LIFE; RHINOSINUSITIS; SCORING SYSTEM; SIDE EFFECT; TERTIARY HEALTH CARE; THROMBOCYTOSIS; TREATMENT FAILURE; TREATMENT RESPONSE; UNITED KINGDOM; UPPER RESPIRATORY TRACT INFECTION; VERRUCA VULGARIS; XERODERMA;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PSORIASIS; QUALITY OF LIFE; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 77957082219     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09986.x     Document Type: Article

References (9)

1. Menter A, Tyring SK, Gordon K et al. Adalimumab therapy for moderate to severe psoriasis: a randomized, controlled phase III trial. J Am Acad Dermatol 2008 58 : 106 115.
2. Warren RB, Brown BC, Lavery D et al. Biologic therapies for psoriasis: practical experience in a U.K. tertiary referral centre. Br J Dermatol 2009 160 : 162 169.
3. Smith CH, Anstey AV, Barker JNWN et al. British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005. Br J Dermatol 2005 153 : 486 497.
4. Fredriksson T, Pettersson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978 157 : 238 244.
5. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994 19 : 210 216.
6. Ryan C, Kirby B, Collins P, Rogers S. Adalimumab treatment for severe recalcitrant chronic plaque psoriasis. Clin Exp Dermatol 2009 34 : 784 788.
7. Papoutsaki M, Chimenti MS, Costanzo A et al. Adalimumab for the treatment of severe psoriasis and psoriatic arthritis. J Am Acad Dermatol 2007 57 : 269 275.
8. Martyn-Simmons C, Green L, Ash G et al. Adalimumab for psoriasis patients who are non-responders to etanercept: open-label prospective evaluation. J Eur Acad Dermatol Venereol 2009 23 : 1394 1397.
9. Pitarch G, Sanchez-Carazo JL, Mahiques L et al. Treatment of psoriasis with adalimumab. Clin Exp Dermatol 2007 32 : 18 22.